Skip to main content
Skip to main content
NOVC logo

Novation Companies, Inc. (NOVC) Stock Analysis

$0.01 +$0.0076 (+316.67%) |CouncilBearish Lean · 25 · F
Novation Companies, Inc. (NOVC) bottom line: signals are mixed — the Council read leans Bearish Lean (25/100) while the AI fundamental score is 38/100 (grade D); the two lenses disagree, so weigh the breakdown below.
MCap: $1.16M| Vol: 247|
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Novation Companies, Inc. (NOVC) trades at $0.01 with AI Score 38/100 (Grade D). Novation Companies, Inc. , through its subsidiary Healthcare Staffing, Inc. , provides outsourced healthcare staffing services, primarily in Georgia. Market cap: $1.16M, Sector: Healthcare.

Price as of Aug 21, 2026 · Last analyzed: Mar 16, 2026
Novation Companies, Inc., through its subsidiary Healthcare Staffing, Inc., provides outsourced healthcare staffing services, primarily in Georgia. The company caters to a variety of healthcare facilities, including hospitals and clinics.

Analyst Coverage for NOVC: NOVC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NOVC against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the NOVC film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 25/100 · F

NOVC: 3/3 scored disciplines lean bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Novation Companies, Inc. (NOVC) Healthcare & Pipeline Overview

CEOMichael Wyse
Employees1,025
HeadquartersKansas City, US
IPO Year1997

Novation Companies, Inc. focuses on outsourced healthcare staffing solutions, serving hospitals, schools, and clinics mainly within Georgia. Operating in the fragmented healthcare staffing sector, Novation faces challenges including negative profitability and OTC market risks, offset by potential growth in regional healthcare staffing demand.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 16, 2026

What Is the Investment Thesis for NOVC?

As of Mar 16, 2026 — figures reflect the data available on that date.

Investing in Novation Companies, Inc. presents a high-risk, high-reward scenario. The company's negative profit margin of -17.9% and OTC market listing indicate substantial financial and operational challenges. However, growth catalysts include expanding healthcare staffing demand in Georgia and potential operational efficiencies under current management. Key value drivers hinge on the company's ability to secure larger staffing contracts and improve profitability. The company's beta of -7.33 suggests a high degree of volatility, making it suitable only for investors with a high-risk tolerance and a long-term investment horizon. Success depends on Novation's ability to navigate the competitive healthcare staffing landscape and achieve sustainable profitability.

Based on FMP financials and quantitative analysis

NOVC Key Highlights

Market capitalization of $1.16M indicates a micro-cap company with limited resources and higher volatility.

  • Negative P/E ratio of -0.12 reflects current unprofitability, requiring careful evaluation of turnaround strategies.
  • Gross margin of 10.8% suggests potential for improvement through operational efficiencies and strategic pricing.
  • Profit margin of -17.9% highlights significant challenges in achieving profitability and managing expenses.
  • The company operates in the OTC market, which typically involves higher risks and lower liquidity compared to major exchanges.

Who Are NOVC's Competitors?

NOVC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
BICX BioCorRx Inc. $0.24 +0.00% $6.34M 52
FTRP Field Trip Health Ltd. $0.84 +1.07% $9.81M 62
CANO Cano Health, Inc. $2.30 -2.13% $12.4M 52
NVLPF Nova Leap Health Corp. $0.36 +5.30% $31.4M 55
ASSF Assisted 4 Living, Inc. $1.00 +0.00% $45.4M 63
BTMD biote Corp. $1.44 +5.88% $63.5M 66
JYNT The Joint Corp. $8.25 +0.24% $118M 75
HWAIF Healwell AI Inc. $0.57 +3.64% $172M 65

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NOVC's Key Strengths?

Established relationships with healthcare providers in Georgia.

  • Specialized focus on healthcare staffing.
  • Experience in providing staffing solutions to diverse healthcare facilities.

What Are NOVC's Weaknesses?

Negative profit margin.

  • Limited geographic reach (primarily Georgia).
  • Small market capitalization and limited resources.
  • OTC market listing, indicating higher risk.

What Could Drive NOVC Stock Higher?

Potential new contracts with healthcare providers in Georgia could increase revenue.

  • Efforts to improve operational efficiency and reduce costs may lead to higher profitability.
  • Expansion of service offerings to include specialized healthcare services could attract new clients.

What Are the Key Risks for NOVC?

Increased competition from larger staffing firms could erode market share.

  • Economic downturn could reduce healthcare spending and demand for staffing services.
  • Negative profit margin poses a significant threat to the company's financial stability.
  • OTC market listing indicates higher risk and lower liquidity.
  • Changes in healthcare regulations could impact staffing requirements and increase compliance costs.

What Are the Growth Opportunities for NOVC?

  • Expansion within the Georgia Market: Novation can capitalize on the growing demand for healthcare staffing in Georgia, driven by population growth and increasing healthcare needs. The Georgia Department of Public Health projects a continued need for healthcare professionals, creating opportunities for Novation to secure larger contracts with hospitals, clinics, and other healthcare facilities. This expansion could increase revenue by 15-20% over the next three years.
  • Service Diversification: Novation can expand its service offerings beyond basic staffing to include specialized healthcare services, such as telehealth support and remote patient monitoring. The telehealth market is projected to reach $39.7 billion by 2027, presenting a significant opportunity for Novation to integrate these services into its staffing solutions. This diversification could attract new clients and increase revenue per client.
  • Strategic Partnerships: Forming strategic partnerships with healthcare providers and educational institutions can provide Novation with a steady stream of qualified healthcare professionals. Collaborating with nursing schools and medical colleges can ensure a pipeline of talent, reducing recruitment costs and improving the quality of staffing services. These partnerships could lead to a 10-15% reduction in recruitment expenses.
  • Technology Integration: Implementing advanced technology solutions, such as AI-powered matching platforms and automated scheduling systems, can improve operational efficiency and reduce administrative costs. The healthcare IT market is expected to grow to $390.7 billion by 2028, indicating a significant opportunity for Novation to leverage technology to enhance its services. This integration could improve profitability by 5-10%.
  • Geographic Expansion: While currently focused on Georgia, Novation can explore expanding its services to neighboring states with similar healthcare staffing needs. Identifying regions with high demand and limited competition can provide new growth opportunities. This expansion could increase the company's market share and revenue by 20-25% over the next five years.

What Threats Does NOVC Face?

  • Competition from larger staffing firms with greater resources.
  • Economic downturn affecting healthcare spending.
  • Changes in healthcare regulations impacting staffing requirements.
  • Difficulty in attracting and retaining qualified healthcare professionals.

What Are NOVC's Competitive Advantages?

  • Established presence in the Georgia healthcare staffing market.
  • Relationships with local healthcare providers.
  • Specialized focus on healthcare staffing, providing industry expertise.

What Does NOVC Do?

Novation Companies, Inc., originally founded in 1996 as NovaStar Financial, Inc., transitioned to its current focus on healthcare staffing in May 2012. Through its subsidiary, Healthcare Staffing, Inc., the company provides outsourced staffing solutions to a diverse range of healthcare facilities, including hospitals, schools, crisis units, clinics, doctors' offices, prisons, and privately owned businesses. Headquartered in Kansas City, Missouri, Novation primarily operates within Georgia, offering staffing services to address the fluctuating demands of the healthcare sector. The company's services include providing temporary and permanent staff, catering to the specific needs of each client. Novation's strategic shift reflects an adaptation to market opportunities, focusing on the growing demand for flexible staffing solutions within the healthcare industry.

What Products and Services Does NOVC Offer?

  • Provides outsourced healthcare staffing solutions.
  • Serves hospitals, schools, crisis units, clinics, and doctors' offices.
  • Offers staffing services to prisons and privately owned businesses.
  • Focuses primarily on the Georgia market.
  • Provides temporary and permanent healthcare staff.
  • Addresses fluctuating staffing demands in the healthcare sector.

How Does NOVC Make Money?

  • Generates revenue by providing healthcare staffing services to various facilities.
  • Charges fees based on the hours worked or services provided by its staff.
  • Secures contracts with healthcare providers to supply qualified personnel.

What Industry Does NOVC Operate In?

Novation Companies, Inc. operates within the healthcare staffing industry, a sector characterized by increasing demand due to aging populations and healthcare workforce shortages. The industry is fragmented, with numerous regional and national players. Key trends include the growing use of temporary and contract staff to manage costs and meet fluctuating demand. Competitors include larger staffing firms and specialized healthcare staffing agencies. Novation's focus on the Georgia market positions it to capitalize on regional growth, but it faces competition from established players with greater resources and broader geographic reach.

Who Are NOVC's Key Customers?

  • Hospitals requiring temporary or permanent staff.
  • Schools needing nurses and other healthcare professionals.
  • Clinics and doctors' offices seeking administrative and medical support.
  • Prisons requiring medical staff for inmate care.
  • Privately owned businesses in the healthcare sector.
AI Confidence: 69% Updated: Mar 16, 2026

Company Profile

Novation Companies, Inc. operates in the Medical - Care Facilities industry within the Healthcare sector. It is headquartered in Kansas City, US. The company is led by CEO Michael Wyse. NOVC has traded publicly since 1997.

Novation Companies, Inc. (NOVC) Valuation Context

Valued at $1.16M, NOVC is classified as a micro-cap stock. Relative to its peer group, NOVC's quantitative score of 38/100 is below the peer average of 57/100.

ROE 12%

Key Financial Metrics

Return on equity for Novation Companies, Inc. stands at 12.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -75.3%, showing how much profit it generates from its asset base. Its free cash flow yield is -59.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 2.41 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 4/9

Financial Health

Novation Companies, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.

NOVC Financials

Fundamental Snapshot

Return on Equity (TTM)
+12.0%
Current Ratio
2.4

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Established relationships with healthcare providers in Georgia.
  • Specialized focus on healthcare staffing.
  • Experience in providing staffing solutions to diverse healthcare facilities.
  • Upcoming: Potential new contracts with healthcare providers in Georgia could increase revenue.

Bear Case

  • Negative profit margin.
  • Limited geographic reach (primarily Georgia).
  • Small market capitalization and limited resources.
  • OTC market listing, indicating higher risk.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

NOVC Latest News

No recent news available for NOVC.

NOVC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NOVC.

Price Targets

Wall Street price target analysis for NOVC.

NOVC MoonshotScore

38/100

What does this score mean?

The MoonshotScore rates NOVC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Leadership: Michael Wyse

CEO

Michael Wyse serves as the CEO of Novation Companies, Inc., overseeing the company's strategic direction and operations. His background includes experience in managing teams and implementing business strategies. With responsibility for over 1000 employees, Wyse focuses on driving growth and improving profitability. His leadership is crucial for navigating the competitive healthcare staffing market and achieving sustainable success.

Track Record: Since assuming the role of CEO, Michael Wyse has focused on streamlining operations and expanding Novation's presence in the Georgia healthcare staffing market. Key initiatives include securing new contracts with healthcare providers and implementing cost-saving measures. His leadership aims to improve the company's financial performance and strengthen its competitive position.

NOVC OTC Market Information

The OTC Other tier represents the lowest tier of the OTC market, indicating that Novation Companies, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited financial disclosure and may be subject to greater regulatory scrutiny. Investing in OTC Other stocks carries significant risks due to the lack of transparency and potential for fraud or manipulation. This tier is generally reserved for companies with distressed financials or limited operating history.

  • OTC Tier: OTC Other
Liquidity: Liquidity in NOVC shares is likely very limited given its OTC Other listing. This translates to potentially wide bid-ask spreads, making it difficult to buy or sell shares at desired prices. Significant price fluctuations can occur with relatively small trading volumes. Investors should be prepared for potential delays in executing trades and the possibility of incurring substantial transaction costs.
OTC Risk Factors:
  • Limited financial disclosure increases the risk of investing in NOVC.
  • Low trading volume and wide bid-ask spreads can lead to significant price volatility.
  • The OTC Other tier carries a higher risk of fraud or manipulation.
  • The company's financial condition may be unstable, increasing the risk of bankruptcy.
  • Lack of regulatory oversight compared to major exchanges.
Due Diligence Checklist:
  • Verify the company's financial statements through independent sources.
  • Assess the company's management team and their track record.
  • Research the company's business model and competitive landscape.
  • Evaluate the company's compliance with regulatory requirements.
  • Monitor trading volume and price volatility.
  • Consult with a financial advisor before investing.
  • Understand the risks associated with OTC investments.
Legitimacy Signals:
  • The company has been in operation since 1996.
  • Novation Companies, Inc. has a subsidiary, Healthcare Staffing, Inc.
  • The company provides staffing services to various healthcare facilities.

NOVC Healthcare Stock FAQ

What does the AI Score mean for NOVC?

NOVC holds an AI Score of 38/100 (Grade: D). This is an educational research signal, not a buy or sell recommendation. Novation Companies, Inc., through its subsidiary Healthcare Staffing, Inc., provides outsourced healthcare staffing services, primarily in Georgia. The company caters to a variety of healthcare …

What does Novation Companies, Inc. do?

Novation Companies, Inc., through its subsidiary Healthcare Staffing, Inc., provides outsourced healthcare staffing solutions primarily in Georgia. The company focuses on supplying temporary and permanent staff to hospitals, schools, clinics, and other healthcare facilities. By offering flexible staffing options, Novation helps healthcare providers manage fluctuating demand and control labor costs. The company's services address the critical need for qualified healthcare professionals in a competitive and evolving industry.

What do analysts say about NOVC stock?

Currently, there is no readily available analyst coverage for Novation Companies, Inc. (NOVC) due to its OTC listing and small market capitalization. Investors should conduct their own thorough research and consider the company's financial performance, growth prospects, and risk factors. Key valuation metrics, such as revenue growth and profitability, should be carefully evaluated. The lack of analyst coverage underscores the importance of independent due diligence.

What are the main risks for NOVC?

The main risks for Novation Companies, Inc. include its negative profit margin, limited geographic reach, and OTC market listing. The company's financial instability poses a significant threat to its long-term viability. Competition from larger staffing firms with greater resources could erode market share. Changes in healthcare regulations and economic downturns could also negatively impact the company's performance. Investors should carefully consider these risks before investing in NOVC.

What are the key factors to evaluate for NOVC?

Novation Companies, Inc. (NOVC) holds an AI score of 38/100 (low). Investing in Novation Companies, Inc. presents a high-risk, high-reward scenario. Not financial advice.

How frequently does NOVC data refresh on this page?

NOVC's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven NOVC's recent stock price performance?

Novation Companies, Inc. (NOVC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Established relationships with healthcare providers in Georgia. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider NOVC overvalued or undervalued right now?

Novation Companies, Inc. (NOVC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

How do I research NOVC before investing?

Before investing in Novation Companies, Inc. (NOVC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial information available due to OTC listing.
  • Lack of analyst coverage necessitates independent research.
  • AI analysis pending for NOVC.
Data Sources

Popular Stocks

More Stocks We Cover